Global Over the Counter (OTC) Drugs & Dietary Supplements Market Insights, Forecast to 2025

1 Study Coverage

• 1.1 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
• 1.2 Market Segments
• 1.3 Key Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type
  • 1.4.2 Analgesic & pain relievers
  • 1.4.3 Dermatological products
  • 1.4.4 Cough, cold, and flu products
  • 1.4.5 Vitamin supplements
  • 1.4.6 Mineral Supplements
  • 1.4.7 Ophthalmic Products
• 1.5 Market by Application
  • 1.5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application
  • 1.5.2 Pharmacies
  • 1.5.3 Grocery Stores
  • 1.5.4 Vitamin
  • 1.5.5 Health Food Stores
  • 1.5.6 Online Pharmacies
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, Estimates and Forecasts
  • 2.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue 2015-2026
  • 2.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales 2015-2026
• 2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements, Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Over the Counter (OTC) Drugs & Dietary Supplements Competitor Landscape by Players

• 3.1 Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers
  • 3.1.1 Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers (2015-2020)
  • 3.1.2 Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Manufacturers (2015-2020)
• 3.2 Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers
  • 3.2.1 Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers (2015-2020)
  • 3.2.2 Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2019
  • 3.2.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Over the Counter (OTC) Drugs & Dietary Supplements Price by Manufacturers
• 3.4 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturing Base Distribution, Product Types
  • 3.4.1 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Type
  • 3.4.3 Date of International Manufacturers Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2015-2020)
  • 4.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020)
  • 4.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2015-2020)
  • 4.1.3 Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Type (2021-2026)
  • 4.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

• 5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2015-2020)
  • 5.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020)
  • 5.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2015-2020)
  • 5.1.3 Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2015-2020)
• 5.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Over the Counter (OTC) Drugs & Dietary Supplements by Country
  • 6.1.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
  • 6.1.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
• 6.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application

7 Europe

• 7.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements by Country
  • 7.1.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
  • 7.1.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
• 7.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements by Region
  • 8.1.1 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region
  • 8.1.2 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
• 8.3 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements by Country
  • 9.1.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
  • 9.1.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
• 9.3 Central & South America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements by Country
  • 10.1.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
  • 10.1.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Type
• 10.3 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Application

11 Company Profiles

• 11.1 Pfizer Inc.
  • 11.1.1 Pfizer Inc. Corporation Information
  • 11.1.2 Pfizer Inc. Description and Business Overview
  • 11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 11.1.5 Pfizer Inc. Related Developments
• 11.2 Novartis International AG
  • 11.2.1 Novartis International AG Corporation Information
  • 11.2.2 Novartis International AG Description and Business Overview
  • 11.2.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 11.2.5 Novartis International AG Related Developments
• 11.3 Roche Holding AG
  • 11.3.1 Roche Holding AG Corporation Information
  • 11.3.2 Roche Holding AG Description and Business Overview
  • 11.3.3 Roche Holding AG Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 11.3.5 Roche Holding AG Related Developments
• 11.4 Merck & Co., Inc.
  • 11.4.1 Merck & Co., Inc. Corporation Information
  • 11.4.2 Merck & Co., Inc. Description and Business Overview
  • 11.4.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 11.4.5 Merck & Co., Inc. Related Developments
• 11.5 Sanofi S.A
  • 11.5.1 Sanofi S.A Corporation Information
  • 11.5.2 Sanofi S.A Description and Business Overview
  • 11.5.3 Sanofi S.A Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 11.5.5 Sanofi S.A Related Developments
• 11.6 Johnson & Johnson
  • 11.6.1 Johnson & Johnson Corporation Information
  • 11.6.2 Johnson & Johnson Description and Business Overview
  • 11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 11.6.5 Johnson & Johnson Related Developments
• 11.7 Gilead Sciences
  • 11.7.1 Gilead Sciences Corporation Information
  • 11.7.2 Gilead Sciences Description and Business Overview
  • 11.7.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 11.7.5 Gilead Sciences Related Developments
• 11.8 GlaxoSmithKline plc.
  • 11.8.1 GlaxoSmithKline plc. Corporation Information
  • 11.8.2 GlaxoSmithKline plc. Description and Business Overview
  • 11.8.3 GlaxoSmithKline plc. Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 11.8.5 GlaxoSmithKline plc. Related Developments
• 11.9 Bayer Healthcare AG
  • 11.9.1 Bayer Healthcare AG Corporation Information
  • 11.9.2 Bayer Healthcare AG Description and Business Overview
  • 11.9.3 Bayer Healthcare AG Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 11.9.5 Bayer Healthcare AG Related Developments
• 11.10 AstraZeneca plc.
  • 11.10.1 AstraZeneca plc. Corporation Information
  • 11.10.2 AstraZeneca plc. Description and Business Overview
  • 11.10.3 AstraZeneca plc. Sales, Revenue and Gross Margin (2015-2020)
  • 11.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 11.10.5 AstraZeneca plc. Related Developments
• 11.1 Pfizer Inc.
  • 11.1.1 Pfizer Inc. Corporation Information
  • 11.1.2 Pfizer Inc. Description and Business Overview
  • 11.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
  • 11.1.5 Pfizer Inc. Related Developments
• 11.12 Alcon Inc.
  • 11.12.1 Alcon Inc. Corporation Information
  • 11.12.2 Alcon Inc. Description and Business Overview
  • 11.12.3 Alcon Inc. Sales, Revenue and Gross Margin (2015-2020)
  • 11.12.4 Alcon Inc. Products Offered
  • 11.12.5 Alcon Inc. Related Developments
• 11.13 Alfresa Pharma Corporation
  • 11.13.1 Alfresa Pharma Corporation Corporation Information
  • 11.13.2 Alfresa Pharma Corporation Description and Business Overview
  • 11.13.3 Alfresa Pharma Corporation Sales, Revenue and Gross Margin (2015-2020)
  • 11.13.4 Alfresa Pharma Corporation Products Offered
  • 11.13.5 Alfresa Pharma Corporation Related Developments
• 11.14 Alkalon A/S
  • 11.14.1 Alkalon A/S Corporation Information
  • 11.14.2 Alkalon A/S Description and Business Overview
  • 11.14.3 Alkalon A/S Sales, Revenue and Gross Margin (2015-2020)
  • 11.14.4 Alkalon A/S Products Offered
  • 11.14.5 Alkalon A/S Related Developments
• 11.15 Alliance Healthcare
  • 11.15.1 Alliance Healthcare Corporation Information
  • 11.15.2 Alliance Healthcare Description and Business Overview
  • 11.15.3 Alliance Healthcare Sales, Revenue and Gross Margin (2015-2020)
  • 11.15.4 Alliance Healthcare Products Offered
  • 11.15.5 Alliance Healthcare Related Developments
• 11.16 Allergan, Plc.
  • 11.16.1 Allergan, Plc. Corporation Information
  • 11.16.2 Allergan, Plc. Description and Business Overview
  • 11.16.3 Allergan, Plc. Sales, Revenue and Gross Margin (2015-2020)
  • 11.16.4 Allergan, Plc. Products Offered
  • 11.16.5 Allergan, Plc. Related Developments
• 11.17 Reckitt Benckiser Plc.
  • 11.17.1 Reckitt Benckiser Plc. Corporation Information
  • 11.17.2 Reckitt Benckiser Plc. Description and Business Overview
  • 11.17.3 Reckitt Benckiser Plc. Sales, Revenue and Gross Margin (2015-2020)
  • 11.17.4 Reckitt Benckiser Plc. Products Offered
  • 11.17.5 Reckitt Benckiser Plc. Related Developments
• 11.18 Bausch & Lomb
  • 11.18.1 Bausch & Lomb Corporation Information
  • 11.18.2 Bausch & Lomb Description and Business Overview
  • 11.18.3 Bausch & Lomb Sales, Revenue and Gross Margin (2015-2020)
  • 11.18.4 Bausch & Lomb Products Offered
  • 11.18.5 Bausch & Lomb Related Developments
• 11.19 AbbVie Inc.
  • 11.19.1 AbbVie Inc. Corporation Information
  • 11.19.2 AbbVie Inc. Description and Business Overview
  • 11.19.3 AbbVie Inc. Sales, Revenue and Gross Margin (2015-2020)
  • 11.19.4 AbbVie Inc. Products Offered
  • 11.19.5 AbbVie Inc. Related Developments
• 11.20 The Colgate-Palmolive Company
  • 11.20.1 The Colgate-Palmolive Company Corporation Information
  • 11.20.2 The Colgate-Palmolive Company Description and Business Overview
  • 11.20.3 The Colgate-Palmolive Company Sales, Revenue and Gross Margin (2015-2020)
  • 11.20.4 The Colgate-Palmolive Company Products Offered
  • 11.20.5 The Colgate-Palmolive Company Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Projections by Region
  • 12.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Regions 2021-2026
• 12.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
  • 12.2.1 North America: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
  • 12.2.2 North America: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
  • 12.2.3 North America: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
• 12.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
  • 12.3.2 Europe: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter's Five Forces Analysis
• 13.5 Primary Interviews with Key Over the Counter (OTC) Drugs & Dietary Supplements Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Over the Counter (OTC) Drugs & Dietary Supplements Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details